October 8th 2024
Light delves into the science behind the new peer-reviewed data assessing benzene presence and formation in benzoyl peroxide products.
September 27th 2024
On the Radar: Emerging Biologics, Topical Anti-Inflammatories, and Systemic Treatments for AD
April 10th 2022Expert panelists discussed the pros, cons, and unknowns of the fast-growing roster of new AD treatments in a session at the 4th Annual Revolutionizing Atopic Dermatitis Conference held April 9 to 11, 2022 in Baltimore, Maryland.
Efficacy of Spesolimab for GPP Flare Treatment
April 1st 2022A poster from the 2022 American Academy of Dermatology Annual Meeting presented subgroup analyses from the Effisayil 1 study that showed the efficacy of spesolimab was consistent across all prespecified patient populations, including those with or without IL-36RN mutations.
Phase 2 Difelikefalin Data for AD to be Presented at AAD 2022
March 11th 2022Cara Therapeutics announced that difelikefalin—its treatment for moderate to severe pruritus in atopic dermatitis patients—was selected for a late-breaker presentation at the 2022 American Academy of Dermatology annual meeting.
2021's Breakthroughs & Disappointments
December 23rd 2021The past year gave dermatologists ample cause for both celebration and frustration as they looked forward to new drugs, devices, and technology to optimize patient care. Here, Dermatology Times® editorial advisory board members weigh in on the good, bad, and still-TBD changes that shaped the specialty during 2021.
New Roflumilast Vehicle Data Announced
December 13th 2021Arcutis Biotherapeutics has announced data suggesting that the vehicle in the investigational roflumilast cream had similar moisturizing properties as a commercially marketed, dermatologist-recommended, ceramide-containing moisturizer in adults with mild eczema.
Galderma, Sofregen Enter Agreement to Develop Silk-based Biostimulators
September 28th 2021Galderma and Sofregen Medical announced they have entered into an agreement to co-develop a novel line of silk-based biostimulators that will enable immediate volume restoration and provide structure for new tissue generation.